D-0750-2021 Class II Terminated
FDA drug recall D-0750-2021 was initiated by Dr. Reddy's Laboratories, Inc. on July 19, 2021 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specification: Some tablets are shaved The recall status is terminated (terminated December 21, 2022). Affected quantity: 37560 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- August 25, 2021
- Initiation Date
- July 19, 2021
- Termination Date
- December 21, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 37560 bottles
Product Description
Tizanidine HCl Tablets, USP 4 mg, 150-count bottles, Rx only, Mfd By: Dr. Reddy's Laboratories limited, Srikakulam District, 532 409 INDIA, NDC 55111-180-15.
Reason for Recall
Failed Tablet/Capsule Specification: Some tablets are shaved
Distribution Pattern
Nationwide within the United States
Code Information
Lot #: T2000471, exp date 09/2023